Respiratory Diseases in Cyclophosphamide-Treated Mice II. Decreased Virulence of PR8 Influenza Virus
AUTOR(ES)
Singer, S. H.
RESUMO
Mice infected intranasally with the PR8 strain of influenza virus were treated with cyclophosphamide, a potent immunologic suppressor. During the first week of infection, mortality in the unmodified influenza infection averaged 65%, whereas in those animals also treated with cyclophosphamide it averaged 22.5%. After the first week, the mortality rate in the infected cyclophosphamide-treated animals rose to that seen during the first week in the animals only infected. This decreased mortality in the first week was found despite the fact that the cyclophosphamide-treated and infected animals had higher virus titers which persisted longer, decreased circulating antibody, and a decreased interferon response. This delayed mortality appeared to be related to the finding of decreased cellular infiltration in the lungs of infected cyclophosphamide-treated animals.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=422471Documentos Relacionados
- Respiratory Diseases in Cyclophosphamide-Treated Mice I. Increased Virulence of Mycoplasma pulmonis
- Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats.
- Brain vascular endothelial cells express JC virus large tumor antigen in immunocompetent and cyclophosphamide-treated hamsters.
- FLUORESCENT ANTIBODY STAINING OF PR8 INFLUENZA VIRUS ADSORBED ON CHICKEN ERYTHROCYTES
- A COMPARISON BETWEEN THE PR8 INFLUENZA VIRUS RECEPTOR AREAS ON FOWL AND ON SHEEP ERYTHROCYTES
